(b)(4) is submitting on behalf of the foreign manufacturer, tosoh corporation, per exemption number (b)(4).This report is being submitted due to a retrospective review conducted under capa(b)(4).On (b)(6) 2017, fse arrived at the site after following up with the customer and learning that the issue had not resolved.Fse replaced the small and large syringe tips, then checked and cleaned the valves and seal.Next, patient samples ran and total areas were back to normal ranges.No further action was required by field service.The most probable cause of the reported event was fault/ failure of the syringe tips.
|
On (b)(6) 2017, the customer reported receiving low total areas on patient samples from their g8 analyzer.She stated that the patient samples that were failing seemed to be "possibly" more viscous.On (b)(6) 2017, a field service engineer (fse) was dispatched to address the reported event, which resulted in delay in reporting of patient results for hba1c.There is no indication of any patient intervention or adverse health consequences due to the delay in reporting of patient results.
|